erythromycin has been researched along with fosfomycin in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (18.52) | 18.7374 |
| 1990's | 4 (14.81) | 18.2507 |
| 2000's | 10 (37.04) | 29.6817 |
| 2010's | 8 (29.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
| Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
| Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
| Besier, S; Brade, V; Kahl, BC; Kraiczy, P; Wichelhaus, TA; Zander, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Blanco, C; Demay, F; Dhalluin, A; Ermel, G; Georgeault, S; Giard, JC; Gillet, R; Gomes Von Borowski, R; Hanh Le, H; Jean, M; Radigue, R; Thepaut, M; Trautwetter, A; Tresse, C; van de Weghe, P | 1 |
| Hardisson, C; Llaneza, J | 1 |
| Triolo, R | 1 |
| Barakett, V; Burghoffer, B; Delisle, F; Guidet, B; Lesage, D; Offenstadt, G; Petit, JC; Richard, G; Vergez, P | 1 |
| Akiyama, H; Arata, J; Kanzaki, H; Shimoe, K; Torigoe, R; Yamada, T | 1 |
| De Luca, M; Dolci, G | 1 |
| Amato, R; Dolci, G; Scaramella, F; Vergnani, M | 1 |
| Hayashi, K | 1 |
| Arimura, K; Higuchi, I; Izumo, S; Kawabata, M; Kubota, H; Maruyama, Y; Nakagawa, M; Nakahara, K; Osame, M | 1 |
| Ito, K; Kawasaki, S; Koyama, T; Otoshi, T; Takami, K; Takizawa, H | 1 |
| Liu, F; Wang, X; Xu, Z | 1 |
| Chakraborty, A; Gloriani, NG; Miyahara, S; Villanueva, SY; Yoshida, S | 1 |
| Kamimura, H; Matsuo, K; Miyazaki, M; Nagata, N; Takata, T; Tanihara, S | 1 |
| Dörries, K; Lalk, M; Schlueter, R | 1 |
| Argemi, X; Baldeyrou, M; Christmann, D; Cianférani, S; Douiri, N; Hansmann, Y; Keller, D; Lefebvre, N; Meghit, K; Meyer, N; Prévost, G; Riegel, P; Ronde Oustau, C; Strub, JM | 1 |
2 review(s) available for erythromycin and fosfomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other antibiotics.
Topics: Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Colistin; Erythromycin; Fosfomycin; Humans; Lincomycin; Orthopedics; Polymyxin B; Tetracyclines; Vancomycin | 1984 |
1 trial(s) available for erythromycin and fosfomycin
| Article | Year |
|---|---|
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antiviral Agents; Ascorbic Acid; Azathioprine; Danazol; Erythromycin; Estrogen Antagonists; Female; Fosfomycin; Glycerol; Human T-lymphotropic virus 1; Humans; Hydrocortisone; Immunoglobulins, Intravenous; Immunosuppressive Agents; Injections, Intramuscular; Injections, Intravenous; Injections, Spinal; Interferon-gamma; Leukapheresis; Male; Methylprednisolone; Middle Aged; Paraparesis, Tropical Spastic; Pentoxifylline; Plasmapheresis; Propiophenones; Respiratory Therapy; Ribonucleosides; Sulfasalazine; Thyrotropin-Releasing Hormone; Vasodilator Agents | 1996 |
24 other study(ies) available for erythromycin and fosfomycin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cystic Fibrosis; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Phenotype; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Thymidine | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Synthesis and evaluation of 1,3,4-oxadiazole derivatives for development as broad-spectrum antibiotics.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Cell Survival; Drug Design; Drug Synergism; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxadiazoles | 2019 |
The action of fosfomycin on the growth of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Chloramphenicol; Culture Media; Drug Interactions; Drug Resistance, Microbial; Erythromycin; Fosfomycin; Lincomycin; Mutation; Oxygen Consumption; Phosphates; Pseudomonas aeruginosa; Sulfadiazine; Tetracycline; Time Factors | 1977 |
[Nephrotoxicity of antibiotics].
Topics: Aminoglycosides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antifungal Agents; Cephalosporins; Chloramphenicol; Erythromycin; Fosfomycin; Humans; Kidney Diseases; Penicillins; Peptides; Rifampin; Tetracyclines | 1976 |
[Bacteriostatic activity and killing curves of eight antibiotics against seven strains of penicillin G-resistant pneumococci].
Topics: Amoxicillin; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Erythromycin; Fosfomycin; Humans; Imipenem; In Vitro Techniques; Penicillin G; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Vancomycin | 1992 |
[Combination effects of fosfomycin and other oral antimicrobial agents against methicillin-resistant Staphylococcus aureus].
Topics: Administration, Oral; Cephalosporins; Doxycycline; Drug Therapy, Combination; Erythromycin; Fosfomycin; Humans; Methicillin Resistance; Minocycline; Skin; Skin Diseases, Infectious; Staphylococcus aureus | 1990 |
[Phosphomycin in tablets that dissolve in the mouth: clinical evaluation in oral medicine].
Topics: Administration, Oral; Erythromycin; Fosfomycin; Humans; Mouth Diseases; Tablets; Tooth Diseases | 1985 |
[Evaluation of the clinical efficacy of fosfomycin lozenges in the prevention of complications in surgical interventions in odontostomatology].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Child; Erythromycin; Female; Fosfomycin; Humans; Male; Middle Aged; Mouth Diseases; Preoperative Care; Tablets | 1985 |
[Effects of various drugs on IL-8 production by eosinophils collected from patients with allergic inflammation].
Topics: Anti-Bacterial Agents; Asthma; Clarithromycin; Eosinophils; Erythromycin; Fosfomycin; Humans; Hypersensitivity; Immunosuppressive Agents; In Vitro Techniques; Interleukin-8; Josamycin; Tacrolimus | 1998 |
[Effects of erythromycin and fosfomycin on Pseudomonas aeruginosa biofilm in vitro].
Topics: Anti-Bacterial Agents; Biofilms; Erythromycin; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2001 |
In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Doxycycline; Erythromycin; Fluorouracil; Fosfomycin; Leptospira; Microbial Sensitivity Tests; Neomycin; Philippines; Rats; Sulfamethoxazole; Trimethoprim; Vancomycin | 2010 |
[Trends and antimicrobial susceptibilities of clinical methicillin-resistant Staphylococcus aureus isolates in Fukuoka University Chikushi Hospital 2008-2012].
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Fosfomycin; Gentamicins; Hospitals, University; Humans; Inpatients; Japan; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Minocycline; Outpatients; Time Factors | 2014 |
Impact of antibiotics with various target sites on the metabolome of Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Erythromycin; Fosfomycin; Metabolic Networks and Pathways; Metabolome; Peptidoglycan; Staphylococcus aureus; Vancomycin | 2014 |
VISLISI trial, a prospective clinical study allowing identification of a new metalloprotease and putative virulence factor from Staphylococcus lugdunensis.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Aminoglycosides; Base Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fluoroquinolones; Follow-Up Studies; Fosfomycin; Fusidic Acid; Humans; Male; Metalloproteases; Methicillin; Middle Aged; Phosphonoacetic Acid; Prospective Studies; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus lugdunensis; Vancomycin; Virulence Factors | 2017 |